The frequency of GSTM1 null genotype was higher in controls (71.67%) than in bladder cancer patients (58.33%), but without statistical significance (OR=0.55; 95% CI=0.26-1.18), (p=0.128). This evidence concerns the gene GSTM1 and urinary bladder carcinoma.